Skip to Content

Vendors


Kevin Smith

Vendors

Inogen moves through ‘rebase year’ 

November 15, 2024Liz Beaulieu, Editor

GOLETA, Calif. – Inogen has put Eric Pauls, vice president of sales for North America, in charge of both its rental and business-to-business channels to reduce friction and scale overall growth.  The move marks a change from a previous sales structure in which separate leaders managed the rental, B2B and direct-to-consumer channels.  “We believe this change will improve alignment across our business and ensure that we are directing every customer and patient to the right...

Read Full Articlered right arrow icon

Elliott Campbell

Vendors

Encore, Trace provide ‘ultimate easy button’ 

November 15, 2024Liz Beaulieu, Editor

LIVINGSTON, Tenn. – Encore Healthcare’s new strategic partnership with Trace Medical helps providers streamline the process of managing ventilator patients and improve their ability to deliver clinical outcomes, say Zach Gantt.  As part of the partnership, Encore Healthcare’s clinical management and compliance services are married with Trace Medical’s vent rental offering to form a one-stop solution called Vent360+.  “We’re working on several partnerships...

Encore Healthcare, Trace Medical, Vent360+, ventilators


Read Full Articlered right arrow icon

Geoff Purtill

Vendors

Invacare sells NA business 

November 11, 2024HME News Staff

ELYRIA, Ohio, and EDISON, N.J. - Invacare Holdings Corp. has sold its North American business to MIGA Holdings, better positioning the business to optimize operations and accelerate growth in the region.  “We are confident that this strategic change will be a benefit to both the North American and European/Asia Pacific businesses of Invacare,” said Geoff Purtill, president and CEO of Invacare Holdings Corporation. “This transaction not only allows us to concentrate on our...

Invacare, Mergers & Acquisitions (M&A), North America


Read Full Articlered right arrow icon

Steve Morgan

Vendors

WellSky adds scale to HME offering

November 8, 2024Liz Beaulieu, Editor

KANSAS CITY – WellSky’s recent acquisition of Bonafide ends a quiet period for the company in the HME market, as it focused more on building up its presence in the larger post-acute care market and amplifying its predictive analytics capabilities.  The company announced in late October that it had acquired Bonafide, an enterprise software solution for HME companies that’s been in the market for 40 years, and retained Mark Ludwig, CEO, to continue to lead that team.  “We...

Bonafide, WellSky


Read Full Articlered right arrow icon

Vendors

Inogen remains focused on growth, innovation, profitability 

November 7, 2024HME News Staff

GOLETA, Calif. - Inogen reported total revenue of $88.8 million for the third quarter of 2024, a 5.8% increase year over year, driven by higher demand and new customer gains across the domestic and international business-to-business channels.   Those gains were partially offset by lower direct-to-consumer sales and rental revenue.  “We continued to make significant progress on our strategic priorities in the third quarter,” said Kevin Smith, president and CEO. Our...

2024, Financial Results, Inogen, Third Quarter (Q3)


Read Full Articlered right arrow icon

Roy Jakobs

Vendors

Philips sees ‘step up’ in Sleep & Respiratory Care 

October 30, 2024Liz Beaulieu, Editor

AMSTERDAM – Uncertainty in China dimmed its overall financial results, but Philips pointed to continued improvements by Sleep & Respiratory Care, part of its Connected Care business, as a highlight for the third quarter of 2024.  While comparable sales were flat for Connected Care, adjusted EBITDA increased 360 basis points to 7.3% with improvements across all businesses, including “an encouraging margin step up in Sleep & Respiratory Care,” said Charlotte Hanneman, CFO.  “The...

Read Full Articlered right arrow icon

Vendors

Philips reports improvement in profitability 

October 28, 2024HME News Staff

AMSTERDAM – Philips reported group sales of EUR 4.4 billion, with flat comparable growth, and adjusted EBITDA margin of 11.8%, up 160 basis points, for the third quarter of 2024.  In the Connected Care business, the company reported comparable sales were flat, with growth in Enterprise Informatics and Sleep & Respiratory Care offset by a low-, single-digit decline in Monitoring, on the back of high-teens growth in the same period last year.  “Strong improvement in profitability...

2024, Financial Results, Philips, Third Quarter (Q3)


Read Full Articlered right arrow icon

Mark Ludwig

Vendors

WellSky buys Bonafide 

October 25, 2024HME News Staff

OVERLAND PARK, Kan. – WellSky has acquired Bonafide, an enterprise software solution for HME companies, in a move that expands the company’s footprint in what it calls “a rapidly growing segment in the health care industry.”  WellSky says its offerings in home infusion and home health are highly complementary to Bonafide’s solutions, industry experience and knowledge.  “With the rise in chronic conditions, a rapidly aging population, and an increased...

Bonafide, Mergers & Acquisitions (M&A), Software, WellSky


Read Full Articlered right arrow icon

Mick Farrell

Vendors

ResMed targets resupply, rePAP for growth

October 25, 2024Liz Beaulieu, Editor

SAN DIEGO – ResMed is redoubling efforts to increase resupply with plans to make Snap, a software platform that monitors orders, performance and patient eligibility in real-time, available to all HME providers, not just those using Brightree.   The company reported a “really solid” 10% increase in sales for mask and accessories in the United States, Canada and Latin America for the first quarter of fiscal year 2025, on an “extraordinary comp” of 23% for...

CPAP, Mick Farrell, ResMed


Read Full Articlered right arrow icon

Mick Farrell

Vendors

ResMed highlights ‘ongoing momentum’ 

October 25, 2024HME News Staff

SAN DIEGO – ResMed’s revenue increased by 11% to $1.2 billion for the first quarter of 2025.  It reported net income of $311.4 million, a 42% increase.  Other results:  Gross margin improved 420 bps to 58.6%; non-GAAP gross margin improved 320 bps to 59.2%  Income from operations increased 34%; non-GAAP income from operations up 27%  Operating cash flow of $326 million  Diluted earnings per share of $2.11; non-GAAP diluted earnings per share...

Financial Results, ResMed


Read Full Articlered right arrow icon